1 insider bought €4,305 of shares over the last 90 days, the latest filed 26 Jul 2026.
Nolato AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for Nolato AB logged 11 filings by 9 insiders.
Only purchases show up on the open market, 8 purchases in all worth €2.4M, filed by 6 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 5 board members and 1 chief executive. Biggest ticket of the year: €1.3M, bought by Lovisa Hamrin and made public on 16 June 2026 (0.11% of market cap).
For context, the typical company on the same exchange (median of 890 companies) published 7 filings over the same period, against 11 filings here. Over the whole record (from 2025), the tally stands at 9 purchases and 1 sale.
Within a 30-day window, 4 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 26 July 2026, 83 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (MAR article 19).
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
+1 other insider
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
13 of 13 declarations
Nolato AB is a Swedish company specializing in the development and manufacturing of plastic solutions for the healthcare and pharmaceutical sectors. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
Purchases our model currently ranks for the recommendations list.
All recommendations